Bipolar Androgen Therapy in the management of prostate cancer
Introduction and purpose: Prostate cancer (PCa) as one of the most frequent neoplasms in men remains a challenge for oncologists. The main strategy of its treatment is the Androgen Deprivation Therapy (ADT) the principle of which is an inducement of hypogonadism. The lack of testosterone is not onl...
Main Authors: | Sylwiusz Niedobylski, Katarzyna Laszczak, Konrad Warchoł, Sara Moqbil, Karolina Kalicka |
---|---|
Format: | Article |
Language: | English |
Published: |
Kazimierz Wielki University
2021-09-01
|
Series: | Journal of Education, Health and Sport |
Subjects: | |
Online Access: | https://apcz.umk.pl/JEHS/article/view/37211 |
Similar Items
-
Therapeutic Potential of Bipolar Androgen Therapy for Castration-Resistant Prostate Cancer: In Vitro and In Vivo Studies
by: Jiwoong Yu, et al.
Published: (2024-01-01) -
Efficacy and safety of bipolar androgen therapy in castration-resistant prostate cancer following abiraterone or enzalutamide resistance: A systematic review
by: Xiangyun You, et al.
Published: (2023-04-01) -
Cardiovascular comorbidities in acromegaly
by: Katarzyna Laszczak, et al.
Published: (2021-08-01) -
Clinical response in metastatic castration‐resistant prostate cancer (mCRPC) cases treated with supra‐physiological doses of testosterone: Bipolar androgen therapy
by: Senji Hoshi, et al.
Published: (2022-02-01) -
Mechanisms of Androgen Receptor Agonist- and Antagonist-Mediated Cellular Senescence in Prostate Cancer
by: Miriam Kokal, et al.
Published: (2020-07-01)